At Infinite Legacy, we realize the power of new and innovative ways in which donors and their families can save and enhance lives beyond traditional organ and tissue donation and transplantation. Through our research programs, donors are able to donate organs, tissue systems and individual tissues unsuitable for transplants to far-reaching medical research and therapy.
In 2022, Infinite Legacy recovered hundreds of non-transplantable organs and tissues from benevolent donors for important medical research. These gifts are helping to save lives because our research partners use the organs and tissue to learn more about disease and develop new and innovative therapies for patients.
This Spring, Infinite Legacy will participate in the pediatric Developmental Genotype-Tissue Expression (dGTEx) project with the National Institutes of Health (NIH) and National Disease Research Interchange (NDRI). Infinite Legacy is one of seven organ procurement organizations (OPOs) who will recover neonatal/pediatric organ and tissue samples to help researchers understand gene expression and function through different stages of development in the pediatric population. This project is important as there is typically a shortage of healthy or “normal” tissue to compare tissues from children with pediatric diseases. The knowledge gained from studying samples could potentially provide hope for children with some of those diseases.